Endtidal Carbon Dioxide for Earlier Detection of Pulmonary Hypertension

NCT03388476 · tracked via the Priya Life Science Germany tracker

Sponsor

University of Giessen

Phase

Observational

Started

2018-05-02

Last updated

2022-05-19

Condition(s) studied

Hypertension, PulmonaryHypertension;Pulmonary;PrimaryChronic Thromboembolic Pulmonary HypertensionVascular DiseasesLung Diseases

Investigational drug(s) / intervention(s)

Capnography

Capnography: Measuring of the exhaled air, especially endtidal co2, through capnography.

Study summary

Measurement of the endtidal carbon dioxide by capnography to exclude or to ensure the diagnosis pulmonary hypertension. The aim of the study is to obtain an endtidal carbon dioxide cut-off value for the diagnostic algorithm for pulmonary hypertension as an easily measurable and cheap diagnostic tool in patients with suspicion of pulmonary hypertension.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Accepted

Inclusion Criteria: Age \> 18 years, suspicion of pulmonary hypertension, planned or accomplished right heart catheterization Exclusion Criteria: none

Primary outcome measure(s)

Measurement PetCO2 — At baseline
Measurement PetCO2 by capnography at rest after or before a right heart catheterization, comparison of the parameter between patients with and without

Trial sites (1)

Facility	City	Region	Status
University Clinic Giessen and Marburg	Giessen	Hesse

More University of Giessen trials in Germany

PVRI GoDeep Global Deep Phenotyping Meta-Registry for Pulmonary Hypertension Recruiting

CEDATA GPGE - a Patient Registry for Children and Adolescents With Inflammatory Bowel Disease Recruiting

Giessen Pulmonary Hypertension Registry and Biobank Recruiting

Giessen Stroke Registry Recruiting

Perioperative Interdisciplinary, Intersectoral Process Optimization in Heart Failure Recruiting

Other trials for the same condition

A Post-Market Clinical Follow-up Study in Patients Treated With Vascular Grafts Recruiting

A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension Active, not recruiting

TrEatment Approach in the Multimodal Era Registry Active, not recruiting

Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension Recruiting

Riociguat in Children With Pulmonary Arterial Hypertension (PAH) Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03388476 on ClinicalTrials.gov ↗ ← All trials in Germany